Amentum (NYSE:AMTM) is now covered by analysts at Raymond James. They set an "outperform" rating and a $30.00 price target on the stock. This represents a 22.9% upside from the current price of $24.41. |
Apellis Pharmaceuticals (NASDAQ:APLS) is now covered by analysts at Morgan Stanley. They set an "equal weight" rating and a $31.00 price target on the stock. This represents a 15.9% upside from the current price of $26.74. |
Broadridge Financial Solutions (NYSE:BR) is now covered by analysts at UBS Group AG. They set a "neutral" rating and a $250.00 price target on the stock. This represents a 9.8% upside from the current price of $227.76. |
The Ensign Group (NASDAQ:ENSG) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $175.00 price target on the stock. This represents a 20.3% upside from the current price of $145.47. |
4D Molecular Therapeutics (NASDAQ:FDMT) is now covered by analysts at Morgan Stanley. They set an "underweight" rating and a $8.00 price target on the stock. This represents a 0.7% downside from the current price of $8.06. |
GE Vernova (NYSE:GEV) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $385.00 price target on the stock. This represents a 9.0% upside from the current price of $353.16. |
International General Insurance (NASDAQ:IGIC) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $30.00 price target on the stock. This represents a 17.6% upside from the current price of $25.50. |
Mativ (NYSE:MATV) is now covered by analysts at Stifel Nicolaus. They set a "hold" rating and a $15.50 price target on the stock. This represents a 22.2% upside from the current price of $12.68. |
Merus (NASDAQ:MRUS) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $73.00 price target on the stock. This represents a 66.6% upside from the current price of $43.83. |
Medicis Pharmaceutical (NYSE:MRX) is now covered by analysts at HSBC Holdings plc. They set a "buy" rating and a $33.00 price target on the stock. This represents a 14.1% upside from the current price of $28.91. |
Northeast Bank (NASDAQ:NBN) is now covered by analysts at Keefe, Bruyette & Woods. They set a "market perform" rating and a $102.00 price target on the stock. This represents a 5.0% upside from the current price of $97.18. |
Stardust Power (NASDAQ:SDST) is now covered by analysts at Roth Mkm. They set a "buy" rating and a $13.00 price target on the stock. This represents a 82.3% upside from the current price of $7.13. |
Sunrise Communications (NASDAQ:SNRE) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "buy" rating on the stock.The current price is $47.00. |
UMB Financial (NASDAQ:UMBF) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $156.00 price target on the stock. This represents a 27.2% upside from the current price of $122.66. |
Vera Therapeutics (NASDAQ:VERA) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $70.00 price target on the stock. This represents a 48.5% upside from the current price of $47.13. |